corporate_fare

Corxel Pharmaceuticals Co. Ltd.

Address: Jc Plaza F 22, 1225 Nanjing West Rd, Jing‘An District

Sponsor Overview

assignment

Specializations

Acute Ischemic Stroke

Corxel Pharmaceuticals Co. Ltd. is engaged in clinical research centered on acute ischemic stroke, with a focus on neurological recovery and post-stroke functional outcomes. The sponsor’s current trial activity reflects interest in treatment approaches for patients affected by sudden cerebral blood flow interruption.

Functional recovery
Modified Rankin Scale outcomes
Neurologic function

Research activity in this area also includes evaluation of safety considerations relevant to stroke care, including the risk of symptomatic intracranial hemorrhage.

Reperfusion and Vascular Neurology

The sponsor’s clinical interests extend to reperfusion-focused stroke management, supporting research on restoring cerebral blood flow and improving outcomes after ischemic events. This places emphasis on acute treatment strategies within vascular neurology.

Cerebral reperfusion
Stroke recovery
Brain ischemia

These research priorities align with efforts to address early neurological impairment and the complications associated with acute stroke intervention.

Neurovascular Safety

Corxel Pharmaceuticals Co. Ltd. also shows interest in the safety profile of therapies used in acute stroke care, particularly hemorrhagic complications that may arise during treatment. This includes clinical attention to bleeding risk in the setting of cerebral ischemia.

Intracranial hemorrhage
Hemorrhagic complications
Stroke treatment safety

Such work is relevant to balancing neurological benefit with treatment-associated vascular risk in patients with ischemic stroke.

Trial Name	Country	Status
Efficacy and Safety Evaluation of JX10 in Acute Ischemic Stroke Patients with Delayed Presentation: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Study	Belgium Bulgaria Finland France Germany Greece Hungary Italy Latvia Lithuania Poland Portugal Spain	Recruiting